The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

NCT00400231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome x

Interventions

DRUG: Study drugs: Metformin and fenofibrate
DRUG: Study Drug: Metformin
DRUG: Study Drug: fenofibrate
DRUG: Metformin and Fenofibrate placebo

Sponsor

University of Pennsylvania

Collaborators

[object Object]